Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance of ADZYNMA Intravenous 1500 (All-Case Investigation)

NCT06441578 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT06441578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06441578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance of ADZYNMA Intravenous 1500 (All-Case Investigation)
Lead sponsor
Takeda
Phase
Observational
Overall status
Recruiting
Start date
May 30, 2024
Completion date
September 30, 2032
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic thrombocytopenic purpura (ttp)